These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of tear proteome in allergic rhinoconjunctivitis patients and controls with respect to pollen season. Tomazic PV; Liesinger L; Pucher B; Thallinger GG; Leitner A; Spoerk S; Gerstenberger C; Lang-Loidolt D; Birner-Gruenberger R Allergy; 2018 Jul; 73(7):1541-1543. PubMed ID: 29574764 [No Abstract] [Full Text] [Related]
5. Preliminary evidence for 'aberrant' expression of the leukocyte integrin LFA-1 (CD11a/CD18) on conjunctival epithelial cells of patients with mite allergy. Pesce G; Ciprandi G; Buscaglia S; Fiorino N; Salmaso C; Riccio AM; Canonica GW; Bagnasco M Int Arch Allergy Immunol; 2001 Jun; 125(2):160-3. PubMed ID: 11435733 [TBL] [Abstract][Full Text] [Related]
6. Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure. Ciprandi G; Pronzato C; Ricca V; Bagnasco M; Canonica GW J Allergy Clin Immunol; 1994 Oct; 94(4):738-46. PubMed ID: 7930308 [TBL] [Abstract][Full Text] [Related]
7. Reduction of soluble ICAM-1 levels in nasal secretion by H1-blockers in seasonal allergic rhinitis. Campbell A; Chanal I; Czarlewski W; Michel FB; Bousquet J Allergy; 1997 Oct; 52(10):1022-5. PubMed ID: 9360756 [TBL] [Abstract][Full Text] [Related]
8. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. Håkansson L; Heinrich C; Rak S; Venge P J Allergy Clin Immunol; 1997 Apr; 99(4):551-62. PubMed ID: 9111502 [TBL] [Abstract][Full Text] [Related]
9. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH; Briscoe M; Widlitz MD J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501 [TBL] [Abstract][Full Text] [Related]
10. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. Ciprandi G; Buscaglia S; Pesce G; Passalacqua G; Rihoux JP; Bagnasco M; Canonica GW J Allergy Clin Immunol; 1995 Feb; 95(2):612-21. PubMed ID: 7531732 [TBL] [Abstract][Full Text] [Related]
11. Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions. Ciprandi G; Cosentino C; Milanese M; Tosca MA Ann Allergy Asthma Immunol; 2003 Apr; 90(4):434-8. PubMed ID: 12722967 [TBL] [Abstract][Full Text] [Related]
12. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression. Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258 [TBL] [Abstract][Full Text] [Related]
13. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764 [TBL] [Abstract][Full Text] [Related]
14. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis. Oh JW; Shin JC; Jang SJ; Lee HB Ann Allergy Asthma Immunol; 1999 Jun; 82(6):579-85. PubMed ID: 10400487 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799 [TBL] [Abstract][Full Text] [Related]
16. Antihistamines and serum adhesion molecule levels. Branco-Ferreira M; dos Santos MC; Palma-Carlos ML; Palma-Carlos AG Allerg Immunol (Paris); 2001 Jun; 33(6):233-6. PubMed ID: 11505807 [TBL] [Abstract][Full Text] [Related]
17. ICAM-1 expression in corneal epithelium of a patient with vernal keratoconjunctivitis: case report. Gill KS; Yannariello-Brown J; Patel J; Nakajima N; Rajaraman S; Trocmé SD Cornea; 1997 Jan; 16(1):107-11. PubMed ID: 8985642 [TBL] [Abstract][Full Text] [Related]
18. Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit. Day JH; Briscoe MP; Ratz JD; Ellis AK; Yao R; Danzig M Allergy Asthma Proc; 2009; 30(3):270-6. PubMed ID: 19549428 [TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study. Hordijk GJ; Antvelink JB; Luwema RA Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731 [TBL] [Abstract][Full Text] [Related]
20. Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. Passalacqua G; Albano M; Ruffoni S; Pronzato C; Riccio AM; Di Berardino L; Scordamaglia A; Canonica GW Am J Respir Crit Care Med; 1995 Aug; 152(2):461-6. PubMed ID: 7633693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]